Dr. Anthony Ting will be participating in a panel discussion at the Virtual Cell and Gene Meeting on the Mesa. This event requires a paid registration to view the webcast. To register for the meeting, please visit the registration site.
OVERCOMING CHALLENGES WITH THE DEVELOPMENT AND TRANSLATION OF A THERAPEUTIC FROM ACADEMIA TO INDUSTRY
Some of the most cutting-edge and innovative approaches to cell and gene therapy have originated from the academic setting. However, getting these treatments into the clinic can be especially challenging when the institution does not have the experience and infrastructure necessary to conduct preclinical studies, manufacture to GMP standards, and file regulatory submissions with the FDA. This panel of experts will discuss their lessons learned throughout the process and best approaches to moving a cell and gene therapeutic candidate from academia to commercialization.
Chair:
Shawn Roach, Ph.D., Specialist-Regulatory CMC, Halloran Consulting Group
Speakers:
Isabelle Riviere, Ph.D., Director, Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center
Anthony Ting, Ph.D., VP of Regenerative Medicine and Head of Cardiopulmonary Programs, Athersys